Corline Biomedical AB (CLBIO) — Free Cash Flow Generation Index
Corline Biomedical AB (CLBIO) has a Free Cash Flow Generation Index of 0.20x as of March 2024. Free cash flow of Skr461.00K represents 0% of operating cash flow (Skr2.30 Million). Explore Corline Biomedical AB capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Corline Biomedical AB Free Cash Flow Generation Index (2023–2023)
Historical FCF Generation Index trend for Corline Biomedical AB across 1 annual periods. For the full cash flow conversion analysis, see CLBIO cash flow metrics.
Annual Free Cash Flow Generation for Corline Biomedical AB (2023–2023)
Year-by-year Free Cash Flow Generation Index for Corline Biomedical AB. Check Corline Biomedical AB (CLBIO) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (SEK) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -10.99x | Skr-9.73 Million | Skr886.00K | Skr10.62 Million | — |